Stocks chugged along in a razor-thin range Monday but squeezed
out slim gains as a cautious equity market prepares for a very
active week of Q1 earnings. Early results were mostly positive with
results from Haliburton (
) and SunTrust (
) beating estimates. Drug stocks were buoyed by rumors of a Pfizer
) and Astra-Zeneca (
) merger, while the semiconductor sector got a bump from positive
earnings from Advanced Micro Devices (
Today's second-tier economic data was all but ignored by the
financial markets. The Chicago Fed found that economic conditions
improved in March as their national index rose to 0.20 last month
from 0.14 the month prior, meeting street consensus.
Leading economic indicators rose 0.8% in March versus the
consensus estimate of +0.7%.
European markets were all closed today for the Easter
Here's where the markets stand at the close:
Dow Jones Industrial Index was up 40 points (0.25%) at
S&P 500 was up 7 points (0.37%) at 1,871
Nasdaq Composite Index was up 26 points (0.64%) at 4,121
FTSE 100 was Closed
Nikkei 225 was down 0.03%
Hang Seng Index Closed
Shanghai China Composite Index was down 1.52%
(+) CBEY (+38.56%) Agreed to be bought by Birch Communications
for $323 million in cash.
(+) SRPT (+39.26%) Plans to submit a New Drug Application to the
U.S. FDA for the approval of eteplirsen as a treatment Duchenne
(+) WB (+11.71%) Long-term growth story highlight by Fortune
(+) ASTM (+24.43%)Agreed to buy Sanofi's (SNY) Cell Therapy and
Regenerative Medicine (CTRM) business for $6.5 million.
(+) AMD (+11.65%) Returned to profit in Q1 following year-ago
net loss, topping analysts' expectations.
(-) SPEX (-6.81%) Filed a $30 million mixed security shelf,
including 1.78 million common shares.
(-) SMT, SMA.TO (-8.28%) Founding directors resign
(-) MGI (-13.47%)Downgraded to market perform from market
outperform at JPM Securities, removed the $25 price target.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.